Ad is loading...
GSILX
Price
$20.73
Change
-$0.16 (-0.77%)
Updated
Nov 15 closing price
RERBX
Price
$53.45
Change
-$0.52 (-0.96%)
Updated
Nov 15 closing price
Ad is loading...

GSILX vs RERBX

Header iconGSILX vs RERBX Comparison
Open Charts GSILX vs RERBXBanner chart's image
Goldman Sachs GQG Ptnrs Intl Opps C
Price$20.73
Change-$0.16 (-0.77%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R2
Price$53.45
Change-$0.52 (-0.96%)
VolumeN/A
CapitalizationN/A
GSILX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSILX vs. RERBX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSILX is a StrongSell and RERBX is a Buy.

FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 129B vs. GSILX (47.2B). GSILX pays higher dividends than RERBX: GSILX (1.29) vs RERBX (1.00). GSILX was incepted earlier than RERBX: GSILX (8 years) vs RERBX (22 years). GSILX is a more actively managed with annual turnover of: 62.00 vs. RERBX (34.00). RERBX has a lower initial minimum investment than GSILX: RERBX (250) vs GSILX (1000). GSILX annual gain was more profitable for investors over the last year : 17.32 vs. RERBX (7.67). GSILX return over 5 years is better than : 52.01 vs. RERBX (3.95).
GSILXRERBXGSILX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD8.3643.077272%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets47.2B129B37%
Annual Yield % from dividends1.291.00129%
Returns for 1 year17.327.67226%
Returns for 3 years12.70-19.42-65%
Returns for 5 years52.013.951,318%
Returns for 10 yearsN/A16.24-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLCE14.040.02
+0.14%
Children's Place
LFLY1.54-0.02
-1.28%
Leafly Holdings
PATH12.37-0.27
-2.14%
UiPath
OTLY0.61-0.04
-5.45%
Oatly Group AB
KYMR41.96-3.99
-8.67%
Kymera Therapeutics